Oral Versus Intravenous Antibiotics for the Treatment of Pleural Space Infection: a Randomized Controlled Pilot Trial

NCT04301869 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-03-10

No results posted yet for this study

Summary

We aim to conduct a pilot trial assessing oral versus intravenous therapy for pleural space infections.

Conditions

  • Pleural Infection

Interventions

DRUG

Antibiotics

Oral versus intravenous therapy

Sponsors & Collaborators

  • Vaibhav Mokashi

    collaborator UNKNOWN
  • St. Joseph's Healthcare Hamilton

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-31
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04301869 on ClinicalTrials.gov